Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Spiriva HandiHaler
A bronchodilator used to prevent wheezing, shortness of breath, and difficulty breathing in patients with chronic obstructive pulmonary disease (COPD) such as chronic bronchitis and emphysema. It is delivered as an oral inhalant once daily.
Read more...
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| COPD (Chronic Obstructive Pulmonary Disease) | 29 | 4 |
|
|
|
||
| Other | 8 | 0 | |||||
| Asthma | 6 | 0 | |||||
| Breathing difficulty with activity | 4 | 1 |
|
||||
| Emphysema | 3 | 0 | |||||
| Asthma | 3 | 0 |
See all 59 patients currently taking Tiotropium Oral Inhalation
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Tiotropium Oral Inhalation
| Dry mouth (xerostomia) | 2 | |
|---|---|---|
| Dizziness | 1 | |
| Blurry vision | 1 | |
| Urinary retention | 1 | |
| Nausea and vomiting | 1 | |
| Feeling of insides shaking | 1 | |
| See all 10 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Tiotropium Oral Inhalation. See all 11 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 2 | ||
| Side effects too severe | 2 | ||
| Not indicated | 2 | ||
| Doctor's advice | 1 | ||
| Other | 1 |
See all 7 patients who’ve stopped taking Tiotropium Oral Inhalation
Adherence
Taking treatment as prescribed
Adherence of Tiotropium Oral Inhalation
Always |
8 | 73% |
|
|---|---|---|---|
Usually |
2 | 18% |
|
Sometimes |
1 | 9% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Tiotropium Oral Inhalation
Very |
2 | 18% |
|
|---|---|---|---|
Somewhat |
1 | 9% |
|
A little |
2 | 18% |
|
Not at all |
6 | 55% |
|
Cost
Paid out of pocket
Cost of Tiotropium Oral Inhalation
$200+ |
1 | 17% |
|
|---|---|---|---|
$100-199 |
1 | 17% |
|
$50-99 |
0 | 0% |
|
$25-49 |
1 | 17% |
|
< $25 |
3 | 50% |
|
Report created on February 12, 2012.